Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Still here but extremely shaky with the lack of news that was promised in last CC. The market is frighten, with everyone looking for any reasons to exit, we will dive much lower with no news.
That is not true. They did stated that the the 40 cent value is a worst case scenario, I.E. when there is no money trial or market crash. Market has not crashed, plenty of funding for trials.
That means there is absolutely no selling or buying interest in Elite.
It doesn't matter if its Harami or Salami, we will bleed with out any news.
What happened to that 500 thousand ask at 30?
Nasdaq, are you familiar with Zohydro new ADT that was submitted yesterday?
That would depend on how the upcoming meeting with FDA goes. If we are given the green light for NDA,then approval is almost certain. Naz said he would bring as much to table on that meeting as possible to make sure nothing is left out before NDA. If meeting goes ok, Potential Partners or buyer should starting cranking numbers and offers as to achieve best possible pricing.
At this point i am looking more towards a Partner, It is the one validation that ELTP need. A Buyer would not only have to validate technology but also market feasibility.
Trading around the core had paid off nicely the last few months but I don't think there is any more flipping opportunities. Trading ranges are getting tighter and with CEO buying in open market PPS bottom is reached. Daily flux of a penny or more are tactics shake loose some weak shares. Obviously CEO is very optimistic that additional studies will not be needed and had said so in last conference.
When CEO just pick up shares on open market. Signs of accumulation has more credence than dumping theories.
I disagree. Submission to FDA is just formality at this point. We will see flux in PPS well into next year up until approval and profit. Investors are not sure about Elite technology, market feasibility, and the overall share float.
Despite the sell off in the last few days and seems to be continuing, the number of shares being traded is still minimal. A few million shares adds up to only a few hundred thousand dollars. In my opinion, had fundamentals changed, we would see heavier volume being traded. "Changing fundamentals" is my greatest fear with this stock. Any thoughts anyone? Please no vulgar private messages. You know who you are.
its not slow bleed anymore, Its a shotgun wound.
HAL study was the most important study released. There were buyers upon the released of this news but there far more sellers. More than the flippers and traders excuse. HAL is probably more important than NDA in my opinion. If there are no Partners within the next few months PPS will continue to slide. Investors must ponder 2 question, 1. Elite ART will not garnish as much market as CEO alluded to.
2. Elite technology is flimsy and will be readily replaced by up and coming technology.
A Partner is the only confirmation that will cause any significant movements on PPS at this point. NDA and approval will not move PPS as much as a Partner.
To Nazrat's credit He did tried to time the release of HAL study and the R and R conference to jolt the stock but i guess there is absolutely no interest in this stock.
Agree, I thought for sure that HAL studies PR was to move the stock up for good but guess not. NDA is just a formality. We might have to wait for approval and launch or may be even profit to ever see 4 dollars.
Looks like its been held down, but by who? Looks like some one has an unlimited amount of shares to unload... Shares seems to be shedding at small enough amount as not to alarm investors, does not look like retailers. This is only possible by someone with intimate knowledge of ELTP PPS direction. Possible Lincoln unloading in anticipation of getting cheaper shares in the near future or worse : It might be the management themselves.
Of course they should be concern when PPS drop 75% of recent year high.
If everyone knows it, we would not be sitting at 30 cents.
Does not look like it will be up too much longer. What a way to pump the stock- highlighting year to year increase in revenue but not stating the obvious quarter to quarter, which is flat... Management looks dirtier and dirtier.
Of course it matters, If they can generate revenues it take pressure off the need to tap into LPC deal.
Just getting 1 ART through FDA, ELTP will have multiple sources financing knocking on their door to do with what ever they want. Ff results from Human liability studies comes back negative, game is over.
I think it is retail scooping up shares they think is cheap. 1-3 million shares trading hands a day is not a lot. That is only 400 thousand to a million dollars. I scooped up more than a hundred thousand in the last 2 days trading. 35% drop on no news seems weird, but i will take my chance and scoop up more shares. Hope its not Nazrat selling... we all would be in trouble :)
Looks like fundamentals are changing. Unlimited amount of shares are up for sale. Someone with a large amount of shares are selling, looks more than just weak hands selling.
CEO accumulating shares in most cases are blessings for share holders but in this case, It might be a curse. Owning so many shares, Mr. Nazrat has hype the stock with phantom evaluation and relentless "Cheerleading" sucking in countless Newbies, Most are in the RED.
When the market is 39 cents and they sell to themselves at 25 cents, it sure spouts confidence in ELTP. They dilute with an additional 300 million share and slowly they sell to themselves at fraction of the cost. They are stealing right under our noses. Retail investors got sucked any where from 97 cents to 30 cents since last CC and they are selling amongst themselves for 25 cent a share. Talk about Ethics.
"Once bitten twice shy". Its seems investors are quite wary of ELTP. After the last Hype pumping this stock to 97 and subsequently burned too many people, folks are afraid to be suckered in again. Its seems like folks just want out of ELTP, any chance to sell at a reduced loss, they are taking it. Maybe NDA will get this going again. The next CC, regardless of what Nasrat said, his credibility is shot, only positive findings in trial, NDA and approval might move this again. Less
I doubt if eltp chose not to have a partner. They could not
find a partner on favorable terms. All that will change when trial results come back positive in two months, hopefully.
I expected ELTP to move the needle at 15 to 20 percent with a PR like this. I guess investors just want out. It looks scary the next few days when the the Hype is over.
Real busy doing what? Human Liability study is the most important thing moving this company forward. Three weeks delay has turned into indedfinite delay. There has to be something wrong with the data from Carmargo.
I am having more and more doubts about ELTP. Just sounds too good to be true at this point. Seems like all the clues are coming together.all the hype at the last CC, the evaluation, etc,. I initially thought that the LPC deal was great news but as it turn out, this is a deal of last resort... No one want a partnership with ELTP. They just don't see the potential here. Its hard to believe that all the big pharma that look at Elite and decide to walk away are wrong.
We are not a secret. ELTP technology has not been independently verified in addition to massive dilution, faulty evaluation to hype the stock, indefinite delay in trial are some reasons why the PPS has been plummeting.
Does anyone want to comment on the indefinite delays on Human Liability study?
Does not look like any Partnerships with ELTP are forming. In addition to no significant update, indefinite delays, and eerie silence from management,folks will likely start to sell.
How about the Human liability study?
That means there will no new update on trial or site transfer.
Please ask if there has been any discussion with the firm that did the Evaluation on current PPS. I am sure if management did do the Evaluation, Nasrat or someone over there should be pretty pissed off at where PPS are at like the rest of us.
There should be increase in PPS over the next few days as Flippers and Traders start adding to their position in anticipation of the upcoming IR meeting. Not hard to guess that there will be some news coming within the next few days.
No disrespect, The very position that Dianne holds with ELTP dictates her response. Her position is created to coax new investors and keep current ones. Calling her will calm your nerves but will not change the facts about ongoing delays.
If you think it is MM driving shares lower, than don't you think it would be beneficial to all those who are trying to get in to ELTP. Cheaper shares for all.